Nature (2014) 4
No regulatory approval exists for AOD-9604 as an OA therapy in any jurisdiction
According to one large study in 9,075 people, having higher blood levels of vitamin B12 was associated with a lower risk of obesity ( Similarly, another study in 976 people showed that having low levels of vitamin B12 was linked to a higher risk of overweight or obesity ( Whats more, a study in 256 children showed that children with lower levels of vitamin B12 tended to have a higher body mass index (BMI), which is a measure of body size determined by height and weight ( However, keep in mind that while these studies show an association between vitamin B12 status and body weight, they dont take other potentially contributing factors into account
How the Peptide Interacts with Fat The primary reason AOD 9604 is studied so heavily is its dual-action approach to fat cells
However, metabolic changes and weight loss take time
hence, it is more preferable than cyanocobalamin for the treatment of vitamin B12 deficiency (1,2,3,4)